Spire Healthcare Group (LON:SPI) Shares Down 16.3% – Time to Sell?

Spire Healthcare Group plc (LON:SPI)’s share price was down 16.3% during trading on Thursday . The company traded as low as GBX 169 ($2.18) and last traded at GBX 188 ($2.42). Approximately 4,929,258 shares traded hands during mid-day trading, an increase of 648% from the average daily volume of 658,925 shares. The stock had previously closed at GBX 224.50 ($2.89).

Spire Healthcare Group Stock Down 16.3 %

The business’s fifty day moving average price is GBX 229.09 and its 200 day moving average price is GBX 230.72. The firm has a market capitalization of £754.90 million, a price-to-earnings ratio of 26.76, a PEG ratio of 1.06 and a beta of 0.96. The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 62.25.

Spire Healthcare Group (LON:SPI) last announced its quarterly earnings data on Thursday, March 6th. The company reported GBX 8.80 ($0.11) earnings per share (EPS) for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. On average, equities analysts expect that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.